CRT-114 Echocardiographic Left Ventricular Hypertrophy Predicts In-hospital Heart Failure in Patients with Non-ST Elevation Myocardial Infarction  by Misumida, Naoki et al.
S12 J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 8 , N O . 2 , S U P P L S , 2 0 1 5
C
O
R
O
N
A
R
Ygroup and control group. Baseline and angiographic characteristics, in-hospital
revascularization procedures, in-hospital and 30-day major adverse cardiac event
(MACE) including death, recurrent myocardial infarction, and target vessel revascu-
larization were compared between the two groups.
RESULTS Among 424 patients included in the ﬁnal analysis, 18 patients (4.2%) had
Wellens’ sign. Among the 18 patients, 9 had a LAD culprit lesion (3 proximal, 5mid, and 1
distal LAD), 2 had a non-LAD culprit lesion, and 4 patients had nonobstructive coronary
artery disease. There was no signiﬁcant difference in the rate of previous myocardial
infarction or percutaneous coronary intervention between the patients with and
without Wellens’ sign. Patients with Wellens’ sign had a higher prevalence of LAD
culprit lesion (50% vs. 22.9%, p¼0.008). Peak troponin I values were comparable be-
tween the two groups (median [interquartile]; 0.92 [0.13-3.7] ng/mL vs. 0.66 [0.10-5.39]
ng/mL, p¼0.80). There was no signiﬁcant difference in the rate of Thrombolysis In
Myocardial Infarction grade 0-1 ﬂow (16.7% vs. 24.6%, p¼0.44), and in-hospital revas-
cularization (55.5% vs. 62.3%, p¼0.56). At the 30-day follow-up, no signiﬁcant differ-
ence was found in the rate of MACE between the two groups (0% vs. 4.2%, p¼0.38).
CONCLUSION Our study demonstrated that 1) Wellens’ sign was observed in 4.2 % in
this cohort; 2) Wellens’ sign had a predictive value for LAD culprit lesion, but it was
also observed in patients with non-LAD culprit lesions; and 3) Wellens’ sign did not
have a short-term prognostic value among patients with NSTEMI.
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Angiographic Thrombus Predicts Larger Infarct Size in Patients with Non-ST
Elevation Myocardial Infarction
Naoki Misumida, Akihiro Kobayashi, John Fox, Yumiko Kanei
Mount Sinai Beth Israel, New York, NY
BACKGROUND Angiographic thrombus is associated with larger infarct size in ST
elevation myocardial infarction (STEMI) population and thrombus aspiration has
been shown to improve coronary perfusion in STEMI. In contrast, a recent random-
ized trial in non-ST elevation myocardial infarction (NSTEMI) population showed
thrombus aspiration did not lead to a reduction in microvascular obstruction. We
aimed to assess the impact of thrombus on infarct size in NSTEMI population.
METHODS We performed a retrospective analysis of 481 consecutive patients with
NSTEMI who underwent coronary angiography within ﬁve days after presentation.
Patients with nonobstructive coronary artery deﬁned as less than 70% stenosis (50%
in the left main coronary artery) were excluded. Infarct size was determined as peak
cardiac troponin I value. Angiographic thrombus was graded according to Throm-
bolysis In Myocardial Infarction (TIMI) grade. High-grade and low-grade thrombi
were deﬁned as TIMI grade 4-5 and TIMI grade 1-3, respectively. Patent infarct-related
artery was deﬁned as TIMI grade 2-3 ﬂow. Clinical and angiographic characteristics,
infarct size and in-hospital major adverse cardiac event (MACE) including death,
recurrent myocardial infarction, and target vessel revascularization were compared
between patients with and without angiographic thrombus.
RESULTS After excluding 103 patients with nonobstructive coronary artery disease,
378 patients were included in the ﬁnal analysis. Among 378 patients, 162 (42.9%)
patients had angiographic thrombus, of which 71 patients had high-grade thrombus.
Peak troponin values were signiﬁcantly higher in patients with thrombus compared
with those without thrombus (median [interquartile]; 3.66 [0.36-13.3] ng/ml vs. 0.69
[0.10-4.36] ng/ml, p<0.001). After excluding patients with TIMI grade 0/1 ﬂow, pa-
tients with thrombus had a higher peak troponin (1.53 [0.27-6.83] ng/ml vs. 0.49
[0.10-2.95] ng/ml, p¼0.003). Patients with thrombus had a higher rate of in-hospital
revascularization (89.5% vs. 68.5%, p<0.001). In the subgroup of the patients who
underwent ad-hoc percutaneous coronary intervention (n¼217), patients with
thrombus had a higher rate of post-procedural TIMI 0 ﬂow (5.5% vs. 0%, p¼0.03).
There was no signiﬁcant difference in the rate of in-hospital MACE.
CONCLUSION Our study demonstrated that angiographic thrombus was associated
with larger infarct size indicated by higher peak troponin values in patients with
NSTEMI, even among patients with patent infarct-related artery.
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BACKGROUND Stent thrombosis is one of the most devastating adverse events
following percutaneous coronary intervention. Stent thrombosis has been reported to
account for about 7% cases of ST elevation myocardial infarction in contemporary
practice and was associated with worse outcomes. In contrast, there are limited data
about non-ST elevation myocardial infarction (NSTEMI) resulting from stent throm-
bosis. Therefore, we aimed to evaluate the prevalence and outcomes of NSTEMI due
to stent thrombosis.
METHODS We performed a retrospective analysis of 481 consecutive patients with
NSTEMI who underwent coronary angiography within ﬁve days after presentation.
Stent thrombosis was deﬁned according to the Academic Research Consortiumcriteria. Infarct size was measured as the peak cardiac troponin I (cTnI) value and a
large myocardial infarction (MI) was deﬁned as a peak cTnI greater than 90th
percentile of the study population. Clinical and angiographic characteristics, the
incidence of a large MI and in-hospital and 30-day major adverse cardiac event
(MACE) including death, recurrent myocardial infarction, and target vessel revascu-
larization were compared between patients with and without stent thrombosis.
RESULTS Among 481 patients, 18 (3.7%) patients had angiographically conﬁrmed
stent thrombosis. There was no signiﬁcant difference in baseline characteristics. At
the time of the events, ten patients with stent thrombosis were taking dual anti-
platelet therapy. There was a trend toward higher peak troponin values in patients
with stent thrombosis (median [interquartile range]; 3.41 [0.15-47.6] ng/ml vs. 0.68
[0.10-5.17] ng/ml, p¼0.13). Patients with stent thrombosis had a higher incidence of
large MI (27.8% vs. 9.3%, p¼0.03). There was no signiﬁcant difference in the rate of
multivessel disease, left anterior descending artery culprit lesion and in-hospital
revascularization. Among patients who underwent ad-hoc percutaneous coronary
intervention, patients with stent thrombus had a higher rate of post-procedural TIMI
grade 0 ﬂow (20.0% vs. 1.9%, p¼0.03). Patients with stent thrombosis had a higher
incidence of in-hospital MACE (11.1% vs. 1.3%, p¼0.03) and 30-day MACE (16.7% vs.
4.1%, p¼0.04).
CONCLUSION Stent thrombosis accounted for 3.7% cases of NSTEMI in this cohort of
patients. Our study showed that patients with NSTEMI resulting from stent throm-
bosis had a higher rate of large MI, in-hospital and 30-day MACE.
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Echocardiographic Left Ventricular Hypertrophy Predicts In-hospital Heart
Failure in Patients with Non-ST Elevation Myocardial Infarction
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BACKGROUND Left ventricular hypertrophy (LVH) is a well-known predictor of heart
failure in the general population. However, its clinical signiﬁcance in the setting of
acute coronary syndrome has not been well established. We aimed to determine the
predictive value of echocardiographic LVH for in-hospital heart failure in patients
with non-ST elevation myocardial infarction (NSTEMI).
METHODS We performed a retrospective analysis of 481 consecutive NSTEMI patients
who underwent coronary angiography within ﬁve days after presentation. Trans-
thoracic echocardiography was performed in a standard fashion during hospitalization
and 309 patients had sufﬁcient data to calculate left ventricular mass index. Obstruc-
tive coronary artery diseasewas deﬁned as stenosis greater than or equal to 70% (50% in
the left main coronary artery). LVHwas deﬁned as left ventricular mass index>95 g/m2
(female) and > 115 g/m2 (male). Baseline and angiographic characteristics, in-hospital
revascularization procedures and heart failure as well as in-hospital and 30-day major
adverse cardiac event (MACE) including death, recurrent myocardial infarction, and
target vessel revascularization were compared between the two groups.
RESULTS Among 309 patients, 91 patients (29.4%) had echocardiographic LVH, 241
patients (78.0%) had obstructive coronary artery disease and 182 patients (58.9%)
underwent in-hospital revascularization. The LVH group had a higher rate of chronic
kidney disease (48.4% vs. 27.1%, p¼0.001). Patients with echocardiographic LVH had
a higher incidence of in-hospital heart failure (33.0% vs. 11.9%, p<0.001). The asso-
ciation between LVH and in-hospital heart failure remained signiﬁcant in the sub-
groups of patients who had obstructive coronary artery disease (31.9% vs. 14.8%,
p¼0.002) and those who underwent in-hospital revascularization (31.1% vs. 14.6%,
p¼0.01). The association between echocardiographic LVH and in-hospital heart fail-
ure persisted after adjusting for age, hypertension, chronic kidney disease and left
ventricular ejection fraction less than 50% (odds ratio 2.35; 95% conﬁdence interval,
1.21-4.56; p¼0.01). At 30-day follow-up, there was a trend toward a higher incidence
of MACE in patients with LVH (6.6% vs. 2.8%, p¼0.11).
CONCLUSION Our study demonstrated that echocardiographic LVH was observed in
a quarter of NSTEMI patients and an independent predictor for in-hospital heart
failure.
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BACKGROUND QT dispersion (Qtd) is deﬁned as the difference between the maximal
and the minimal values of the QT through the peripheral and precordial leads. It is
considered as an arrhythmogenic indice and reﬂects the inhomogeneity of
repolarization.
AIM To investigate the effect of revascularization on corrected QT interval (QTc) and
Qtd in acute STEMI patients.
METHODS We conducted a prospective study in which patients presenting with acute
STEMI who underwent primary percutaneous coronary intervention (PCI) with suc-
cessful recanalization were enrolled. QTc and QTd were calculated before, 90 minutes
